What is true regarding leukotriene modifiers for adults with asthma?

Leukotriene modifiers are considered less effective than inhaled corticosteroids for controlling asthma symptoms in adults. Inhaled corticosteroids are the cornerstone of asthma management because they directly reduce airway inflammation, leading to better control of asthma symptoms and a decrease in the frequency of exacerbations. Studies have consistently shown that inhaled corticosteroids provide a more potent anti-inflammatory effect compared to leukotriene modifiers.

Although leukotriene modifiers can be beneficial as an add-on therapy or for patients who prefer an oral medication, they are not regarded as first-line treatment. Their role is more focused on patients with mild asthma or as a complement to inhaled corticosteroids. Consequently, the effectiveness of leukotriene modifiers in controlling asthma is typically not as robust as that provided by inhaled corticosteroids, supporting the assertion that leukotriene modifiers are less effective for adults with asthma when viewed as a primary treatment option.